Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny 
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network 
Starlink Internet Remains Active in Iran Despite Nationwide Blackout 
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows 
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
SAN FRANCISCO, March 24, 2017 -- Hagens Berman Sobol Shapiro LLP updates investors in USANA Health Sciences (NYSE:USNA) regarding the Company’s recent admitted weaknesses in internal controls over financial reporting and reminds them of the April 14, 2017 Lead Plaintiff deadline in the pending securities class action.
If you purchased or otherwise acquired securities of USNA between March 14, 2014 and February 7, 2017 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/USNA
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On February 7, 2017, USNA announced that it is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. concerning compliance with the Foreign Corrupt Practices Act (“FCPA”) and certain conduct and policies at BabyCare, including BabyCare’s expense reimbursement policies. The Company hired outside counsel to conduct the investigation and notified both the SEC and the U.S. Department of Justice of the investigation.
This news drove the price of USNA shares down over 11.5% to close at $55.40 on February 8, 2017.
On March 1, 2017, USNA disclosed it identified a material weakness in its internal control over financial reporting as of December 31, 2016 in connection with the internal investigation into compliance with the FCPA.
“We’re concerned that if in fact there were FCPA violations, they would have occurred in the Company’s largest operations,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding USNA should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
